Concepedia

Author

Friedrich Rippmann

Merck (Germany)ORCID

Also Known As

F Rippmann, F. RIPPMANN, F. Rippmann, Friedrich F. Rippmann, Friedrich Rippmann, Rippmann, Friedrich

66

Publications

4.1K

Citations

23

H-Index

72

Concepts

All Affiliations

Merck (Germany)BioMed X InstituteUniversität HamburgGerman Cancer Research CenterHeidelberg University
FR

About

Friedrich Rippmann is an author at Merck (Germany) specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

23

1.8K

2

Natural Sciences

10

11

1.3K

3

Engineering

8

8

376

4

Biochemistry

8

8

1.1K

5

Biomolecular Engineering

4

4

208

Friedrich Rippmann

×

38

Publications

3.9K

Citations

23

H-Index

YearCitations

LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins

Manfred Hendlich, Friedrich Rippmann, Gerhard Barnickel

Journal of Molecular Graphics and Modelling

1997

735

DoGSiteScorer: a web server for automatic binding site prediction, analysis and druggability assessment

Andrea Volkamer, Daniel Kühn, Friedrich Rippmann,

Bioinformatics

2012

566

Combining Global and Local Measures for Structure-Based Druggability Predictions

Andrea Volkamer, Daniel Kühn, Thomas Grombacher,

Journal of Chemical Information and Modeling

2011

481

KinMap: a web-based tool for interactive navigation through human kinome data

Sameh Eid, Samo Turk, Andrea Volkamer,

BMC Bioinformatics

2017

342

Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects

Christina Schindler, Hannah M. Baumann, Andreas Blum,

Journal of Chemical Information and Modeling

2020

292

Computational approaches to identifying and characterizing protein binding sites for ligand design

Stefan Henrich, Outi M. H. Salo‐Ahen, Bingding Huang,

Journal of Molecular Recognition

2009

216

A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA.

Friedrich Rippmann, William R. Taylor, Jonathan B. Rothbard,

The EMBO Journal

1991

191

Profiling Prediction of Kinase Inhibitors: Toward the Virtual Assay

Benjamin Merget, Samo Turk, Sameh Eid,

Journal of Medicinal Chemistry

2016

121

An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity

Jan Konvalinka, M A Litterst, Reinhold Welker,

Journal of Virology

1995

112

MELLODDY: Cross-pharma Federated Learning at Unprecedented Scale Unlocks Benefits in QSAR without Compromising Proprietary Information

Wouter Heyndrickx, Lewis Mervin, Tobias Morawietz,

Journal of Chemical Information and Modeling

2023

94

Page 1